Semaglutide, tirzepatide, and bariatric surgery were linked to lower rates of obesity-associated cancers compared with DPP-4i.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback